Lyfius Pharma Private Limited is a Private company incorporated on 16 November 2020. It is classified as Non-government company and is registered at Registrar of Companies, Vijayawada. Its authorized share capital is Rs. 1,000,000 and its paid up capital is Rs. 1,000,000. It’s NIC code is 242 …
Lok-Beta Pharmaceuticals Walk In Interview 2024.Lok-Beta Pharmaceuticals Notification full details below..Interested and eligible candidates can attend interview on scheduled time and venue.Concept of backward integration from exporting to Manufacturing was conceived by Mr. Alok Kumar (Founder and Managing Director) in early millennium era when entire world …
Aragen Life Sciences(GVK Bio) Walk In Interview 2024.Aragen Life Sciences(GVK Bio) Notification full details below..Interested and eligible candidates can attend interview on scheduled time and venue.Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your …
QA/QC/R&D/Production/Operational Excellence/Supply chain Management Walk-in On 16th Nov 2024 At Ahlcon Parenterals (India) Limited, a B. Braun group Granules India Ltd Walk-in On 16th Nov 2024 ITI/Diploma/D.Pharm/B.Sc/B.Pharm/M.Pharm/M.Sc for Multiple Positions Freshers & Experience Walk-in On 16th Nov 2024 AT Anthem BioSciences Syngene International Ltd Walk-in …
Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the State of Gujarat. Over the last seven decades, the company has been developing and manufacturing pharmaceutical products in India and selling and distributing these in over hundred …
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at http://www.cognizant.com or @cognizant. Vacancy details: Department: Voice – BPO Experience: 0 years …
Stocks to watch: Mankind Pharma Limited has pledged 39.68 per cent of its equity stake in its fully-owned subsidiary Bharat Serums and Vaccines Limited (BSV) to secure non-convertible debentures (NCDs) totalling ₹5,000 crores. This decision comes under SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015, with Catalyst Trusteeship …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
